Abstract
Kalamazoo, Michigan–based Vestaron has closed a $40 million series B financing round led by Novo Holdings, parent company of Novo Nordisk and Novozymes. Vestaron develops biopesticides based on peptides found in spider venom. The start-up says they could prove to be environmentally friendly alternatives to synthetic crop protection chemicals. The company thus far has two products: one for greenhouse pests such as thrips, whiteflies, aphids, and mites and another for lepidopterans such as moths.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
